Ahmed Fadhil Hashim

Molecular Docking and Dynamics Simulation of a Screening Library from Life Chemicals Database for Potential Protein-Protein Interactions (PPIs) Inhibitors against SARS-CoV-2 Spike Protein

Hasanain Abdulhameed Odhar, Salam Waheed Ahjel, Ahmed Fadhil Hashim & Ali Mahmood Rayshan · Journal of Pharmaceutical Research International · 2021

The ongoing pandemic of coronavirus 2 represents a major challenge for global public health authorities. Coronavirus disease 2019 can be fatal especially in elderly people and those with comorbidities. Currently, several vaccines against coronavirus 2 are under application in mul...

Open access Research Article 10.9734/jpri/2021/v33i20A31350

Virtual Screening of FDA Approved Drugs Library to Identify a Potential Inhibitor against NS2B-NS3 Protease of Yellow Fever Virus

Hasanain Abdulhameed Odhar, Salam Waheed Ahjel, Ali A. Mohammed Ali Albeer, Ahmed Fadhil Hashim & Suhad Sami Humadi · Journal of Pharmaceutical Research International · 2021

Yellow fever is a neglected hemorrhagic disease with a high case fatality rate ranging between 25% and 50% for the hospitalized patients. Yellow fever disease is caused by a zoonotic pathogen known as yellow fever virus. This RNA virus is usually transmitted by mosquitos and it i...

Open access Research Article 10.9734/jpri/2021/v33i51B33528

Screening of Human Epidermal Growth Factor Receptor 2 (HER2) Extracellular Domain for Potential Epitopes by Using Immuno-informatics Tools

Hasanain Abdulhameed Odhar, Salam Waheed Ahjel, Zanan Abdulhameed Odhar, Suhad Sami Humadi, Ali Mahmood Rayshan & Ahmed Fadhil Hashim · Journal of Pharmaceutical Research International · 2021

The human epidermal growth factor receptor 2 (HER2) is a well-studied oncoprotein that is overexpressed in a considerable proportion of breast cancer patients. The increased expression of this tyrosine kinase receptor is usually associated with poor clinical prognosis in female p...

Open access Research Article 10.9734/jpri/2021/v33i22A31383